Furthermore, the conflicting nature of some results—particularly those across different breast cancer subtypes—implies that the FOXC1-dependent transcriptional program is highly context-specific and that poorly-characterized subsets of FOXC1 target genes likely determine the differing metastatic capacities of cancer subtypes [43]. The gene discussed is FOXC1; the disease is cancer.